M1478 HCPCS Level II code: Psychoactive substance abuse
M1478 is the HCPCS code for “Psychoactive substance abuse” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
M1478Psychoactive substance abuse
Short description: Psychoactive sub abuse
HCPCS · United States
Medicare details
The indicators CMS publishes with M1478 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Undefined codes
- Added
- Jan 1, 2026
Where M1478 sits
- 1M codesMedical services and quality measures
- 2Active code M1478Psychoactive substance abuse
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code M1478 mean?
M1478 is the HCPCS code for “Psychoactive substance abuse” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover M1478?
CMS lists M1478’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside M1478
All M codesM1472Patient did not receive recommended doses of hepatitis b vaccination based on ageM1473Patient situations, at any point during the denominator identification period, where the patient's functional capacity or motivation (or lack thereof) to improve may impact the…M1474Patients with diagnosis of dementiaM1475Patients with diagnosis of huntington's diseaseM1476Patients with diagnosis of cognitive impairment or alzheimer's diseaseM1477Diagnosis of deliriumM1479Patients whose functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools such as delirium, dementia, intellectual…M1480Patients whose functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools such as delirium, dementia, intellectual…M1481Patients receiving hospice or palliative care or who died during the measurement periodM1482Positive/detectable hepatitis c virus quantitative or qualitative rna test result during the denominator identification periodM1483Patients who achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks…M1484Patients who did not have a repeat hcv rna labs performed for medical reasons documented by clinician (e.g., patient with limited life expectancy, delay in treatment of hcv…